The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes.

President-elect Donald Trump, a Biden administration proposal would require Medicare and Medicaid to cover weight-loss drugs ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...